|
⚲
|
| Keyboard |
| James Loughlin | |
|---|---|
| Firm | |
| Address | 321 Columbus Avenue Boston, MA 02116 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| InspireMD Inc | 021-260088 | Director | 0.6 M of 0.6 M |
||
| Edge Therapeutics Inc | 021-237569 | Director | 56.0 M of 56.0 M |
||
| Edge Therapeutics Inc | 021-228305 | Director | 7.9 M of 25.0 M |
||
| Edge Therapeutics Inc | 021-193853 | Director | 6.7 M of 20.0 M |
||
| InspireMD Inc | 021-190507 | Director | 3.1 M of 3.1 M |
||
| InspireMD Inc | 021-186426 | Director | 1.8 M of 1.8 M |
||
| InspireMD Inc | 021-185798 | Director | 0.5 M of 0.5 M |
||
| InspireMD Inc | 021-184855 | Director | 0.4 M of 0.4 M |
||
| InspireMD Inc | 021-184854 | Director | |||
| Edge Therapeutics Inc | 021-184201 | Director | 0.1 M of 3.0 M |
||